包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
500 μg | 电议 |
1mg | 电议 |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
生物活性 | IRL-1620 (TFA) is a potent and selectiveendothelin receptortype B (ETB)agonist with aKiof 16 pM[1]. | ||||||||||||||||
IC50& Target | IC50: 16 pM (Endothelin receptor B); 19 μM (Endothelin receptor A)[1] | ||||||||||||||||
体外研究 (In Vitro) | IRL-1620 (TFA) is the most potent and specific ligand for the ETB receptor (KiETA/ KiETB=120,000) as judged by the Kivalues for ETA (19 μM) and ETB (16 PM) receptors[1].IRL-1620 (TFA) is 60 times more selective for the ETB receptor than ET-3 (KiETA/ KiETB=1,900)[1]. | ||||||||||||||||
体内研究 (In Vivo) | IRL-1620 (TFA) (1-100 nM) induces contractions of the guinea pig trachea. The effective concentration that produces 30 % of 60 mM KCI-induced contraction is estimated to be 28 nM for IRL-1620[1].IRL-1620 (TFA) (1-100 nM) increases cytosolic Ca2+in the vascular endothelium ([Ca]E) with little effect on resting muscle tone, and relaxes the norepinephrine-stimulated tone with an increase in [Ca]E, in rat aorta,[1].IRL-1620 (TFA) improves both acquisition (learning) and retention (memory) on the water maze task and enhances angiogenic and neurogenic remodeling. Rats treated with IRL-1620 significantly reduces the cognitive impairment induced by Aβ. IRL-1620 treatment enhances the number of blood vessels labeled with VEGF compared to vehicle treatment[2].IRL-1620 (TFA), restores analgesic tolerance to morphine and oxycodone, but it does not affect morphine and oxycodone induced decrease in NGF/PI3K expression. IRL-1620 attenuates opioid tolerance without the involvement of NGF/PI3K pathway[3]. | ||||||||||||||||
分子量 | 1934.97 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C88H118F3N17O29 | ||||||||||||||||
Sequence | {Suc}-Asp-Glu-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp | ||||||||||||||||
Sequence Shortening | {Suc}-DEEAVYFAHLDIIW | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | Sealed storage, away from moisture and light
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 50 mg/mL(25.84 mM;Need ultrasonic) H2O :< 0.1 mg/mL (ultrasonic)(insoluble) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |